|Articles|June 15, 2002

BioPharm International

  • BioPharm International-06-01-2002
  • Volume 15
  • Issue 6

Business Matters: Is a Turnaround in Sight?

by G. Steven Burrill, Burrill & Company After a strong finish in 2001, biotech is back in the dumps.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.